Project Grant R01DA060576

Award Date 7/1/24
Completion Date 4/30/29
Dollars Obligated $1.5M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award of $693,129 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to understand the role of chromatin regulation and BDNF expression in the ventral tegmental area (VTA) of the brain in driving persistent drug-seeking behaviors associated with cocaine addiction. The project will use innovative molecular genetic techniques to define changes in the 3D chromatin architecture and gene expression...
The University of Washington was awarded a $149,284 Project Grant by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the role of specific subpopulations of prefrontal cortex pyramidal neurons in regulating drug-seeking behavior. The research aims to elucidate the factors that predispose individuals to addiction and confer vulnerability to relapse, with the goal of advancing understanding of the functional roles of...
This Project Grant award, valued at $1,447,919.00 and provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding the mechanisms underlying cocaine addiction and testing interventions to address it. The key research objectives are to: 1) Evaluate whether treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist can block the aversive behavioral and physiological responses to a...
This $1,351,034 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the mechanisms by which somatostatin-expressing interneurons in the prefrontal cortex of the brain regulate natural and drug reward seeking behaviors. The key objectives are to: 1) reveal the in vivo dynamics, behavioral contributions, and neural circuit connections of these interneurons during natural and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program 93.279 "Drug Use and Addiction Research Programs," provides $1,996,709.00 over a 5-year period from September 30, 2024 to May 31, 2029. The primary focus of the project is to investigate the role of cortical excitatory projections in cocaine addiction. The key objectives are to: 1) examine the excitability of cortical pyramidal neurons in the supplementary motor cortex (M2)...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $153,512 to support research aimed at understanding and disrupting the neural basis of drug-context memories that can trigger relapse in addiction. The primary objectives are to 1) test if inhibiting dentate gyrus neurons active during reward-context memory encoding can reduce the recall of drug-linked context memories, and 2) determine if...
This $1,118,601 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research into the role of orexin (hypocretin) signaling in the ventral tegmental area as a common mechanism linking sleep disturbances and drug demand during cocaine abstinence. The key objectives are to: 1) Determine if sleep disturbances persist during protracted cocaine abstinence and how they relate to orexin neuron activity;...
The National Institute on Drug Abuse (NIDA) has awarded a $492,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Chicago to conduct a multidimensional study on the genetic and epigenetic factors underlying cocaine addiction. The 5-year project aims to: Perform high-resolution chromatin accessibility and DNA methylation profiling to delineate cell-type and circuit-specific epigenetic changes following cocaine self-administration in mice. This will...
This Project Grant award of $1,076,036 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to characterize electroencephalography (EEG) signatures and the role of prefrontal cortex (PFC) interneuron subtypes in opioid use disorder (OUD). The key objectives are to: 1) Test how individual differences in PFC theta power and interneuron physiology correlate with fentanyl self-administration and affective disturbances...
This $903,965.00 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to determine the role of distinct prefrontal cortex circuits in controlling heroin-seeking behavior and opioid use disorder (OUD) pathology. The key objectives are to: 1) Identify whether recruitment of a prefrontal driver circuit is a hallmark of heroin-induced pathology, 2) Investigate whether this driver circuit engages a positive feedback...

DIFFERENTIAL ROLES OF PREFRONTAL CORTICAL INTERNEURONS IN DRUG SEEKING AFTER WITHDRAWAL - PROJECT SUMMARY DRUG CRAVING DURING PROLONGED PERIODS OF ABSTINENCE IS A MAJOR FACTOR DRIVING REPEATED CYCLES OF DRUG ABUSE. GIVEN THE ESCALATING PREVALENCE OF SUBSTANCE ABUSE, IT IS IMPERATIVE TO HAVE A THOROUGH UNDERSTANDING OF THE BRAIN CIRCUIT PLASTICITY AND ASSOCIATED MOLECULAR MECHANISMS THAT SPECIFICALLY UNDERLIE DRUG SEEKING. NONETHELESS, DESPITE SEVERAL DECADES OF RESEARCH, THE NEURAL CIRCUIT MECHANISMS UNDERLYING STRONG CRAVINGS FOR DRUGS AFTER ABSTINENCE ARE NOT FULLY ELUCIDATED. THE MEDIAL PREFRONTAL CORTEX (MPFC) IS ASSOCIATED WITH VARIOUS COMPLEX BEHAVIORS INCLUDING WORKING MEMORY, IMPULSIVITY, GOAL-DIRECTED ACTION, AND DECISION-MAKING. GIVEN THE DIVERSE ROLES OF THE PFC AND ITS EFFERENT AND AFFERENT CONNECTIONS TO LIMBIC REWARD CIRCUITRY, THE PFC IS CAPABLE OF INTEGRATING AND TRANSMITTING DRUG-RELEVANT SIGNALS THROUGHOUT THE BRAIN AS THE ADDICTION PROGRESSES. IN PARTICULAR, SEVERAL REPORTS SHOW THAT VENTRAL PFC SUBREGIONS MODULATE DRUG-SEEKING AND EXTINCTION BEHAVIOR AND ARE A VIABLE TARGET FOR DEEP BRAIN STIMULATION TO REDUCE ADDICTIVE BEHAVIORS. HOWEVER, IT IS LARGELY UNKNOWN HOW PFC SUB-CIRCUITRIES CONTRIBUTE TO DRUG ADDICTION DIFFERENTIALLY AND WHETHER SPECIFIC CELL TYPES, ESPECIALLY DISTINCT TYPES OF INTERNEURONS, WITHIN THE PFC ARE DIFFERENTIALLY RESPONSIBLE FOR DRUG-SEEKING AFTER WITHDRAWAL AND EXTINCTION. IN THIS PROPOSED RESEARCH, WE WILL INVESTIGATE THE ROLE OF DIFFERENT INTERNEURONS IN THE INFRALIMBIC (VENTRAL) CORTEX FOR THE SEEKING AND THE EXTINCTION OF COCAINE AFTER WITHDRAWAL IN OUR NEWLY DEVELOPED HEAD-FIXED DRUG SELF-ADMINISTRATION PARADIGM. FIRST, WE WILL DIRECTLY MONITOR THE ACTIVITY OF DIFFERENT TYPES OF INTERNEURONS, PARVALBUMIN (PV)-, SOMATOSTATIN (SST)-, AND VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)- EXPRESSING NEURONS, IN INFRALIMBIC CORTEX (IL) DURING COCAINE SELF-ADMINISTRATION AT SINGLE-NEURON RESOLUTION USING MULTIPHOTON PHOTON MICROSCOPY. SECOND, WE WILL DIRECTLY MANIPULATE THE ACTIVITY OF DISTINCT INTERNEURONS AT THE SPECIFIC TIMING OF DRUG SELF-ADMINISTRATION TO EXAMINE THE CAUSAL ROLES OF THESE NEURONS IN DRUG SELF- ADMINISTRATION. THIRD, WE WILL EXAMINE HOW CORTICAL OUTPUTS ARE REGULATED BY DISTINCT INTERNEURONS DURING DRUG SELF-ADMINISTRATION. EXCITINGLY, WE ALREADY ACQUIRED PRELIMINARY RESULTS SHOWING THE DIFFERENTIAL ROLES OF DISTINCT INTERNEURONS IN COCAINE SELF-ADMINISTRATION. OVERALL, WE BELIEVE THAT THE SUCCESSFUL COMPLETION OF THIS PROJECT WILL YIELD SIGNIFICANT BENEFITS BY ESTABLISHING A FRAMEWORK FOR THE RESEARCH OF DRUG ADDICTION IN A CIRCUIT-SPECIFIC MANNER, AS WELL AS BY FACILITATING THE DEVELOPMENT OF A TREATMENT APPROACH FOR DRUG ADDICTION.

Posted 6/27/24, 12:00 AM